• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

AcelRx Pharmaceuticals, Inc.

by FSA Webmaster

Booth #304

351 Galveston Drive
Redwood City, CA  94063
Telephone: (650) 216-3500
Fax: (650) 216-6500
Website: www.acelrx.com

AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on innovative therapies for the treatment of acute and breakthrough pain. Our lead product, a sublingual sufentanil tablet system, is designed to address IV PCA problems, such as the inherent potential for programming and delivery errors associated with the complexity of infusion pumps.

Category: 2014 Exhibits, 2015 ExhibitsTag: AcelRx Pharmaceuticals, Inc.

About FSA Webmaster

Previous Post:Media Release – FSA Survey
Next Post:Anesthesia Business Consultants

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved